Agree
mrd so far looks inferior on what data both have released
both look pretty average although mrd are far less productive in informing the market of progress towards viability (if there is such progress)
Very disappointing management
no one appears to be managing mrd and no timelines or indications to market when the work will be finished.
Ann: Maiden Inferred MRE for Mia Prospect, page-37
Add MRD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.784M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $196 | 196.2K |
| MRD (ASX) Chart |